Page results
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
We are part of the MRC Centre for Neuromuscular Diseases and our team is actively involved in cutting-edge neuroscience research.
-
This page has been written for patients who are having radiotherapy to the breast or chest wall area.
-
How to refer to infectious and tropical diseases.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
This page is for children and young people receiving Proton beam therapy. It explains what growth monitoring is and why it is important.
File results
-
FOI/2024/0147 - Permits to Work
-
FOI/2024/0151 - A&E decision-to-admit wait times 2019-2023
-
FOI/2024/0158 - Procedures cancelled due to issues with defective diagnostic equipment
-
FOI/2024/0169 - Medical emergency protocols
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0182 - Women diagnosed with Endometriosis 2019 to 2023
-
FOI/2024/0211 - Acute admissions of women aged 18 to 35 for gynaecology, urology or general surgery 2013-2023
-
FOI/2024/0215 - Agency nursing shifts Band 2 and Band 5 from April 2023 to March 2024
-
FOI/2024/0237 - Staff access to NHS intranet
-
FOI/2024/0238 - Haematology and immunoglobulin treatments